Skip to main content
. Author manuscript; available in PMC: 2019 May 7.
Published in final edited form as: Mol Pharm. 2018 Apr 2;15(5):1766–1777. doi: 10.1021/acs.molpharmaceut.7b01013

Figure 9. Effects of MIDD0301 on cytokine expression in the lung.

Figure 9

Mouse Th1/Th2/Th17 cytokines were quantified in mouse tissue homogenates using the BD mouse Th1/Th2/Th17 cytometric bead array kit. Ova s/c mice were administered vehicle or 100 mg/kg MIDD0301 (vehicle 2% hydroxypropyl methylcellulose and 2.5% polyethylene glycol) via oral gavage twice daily for 5 days. Data represent mean ± SEM from 10 mice in each group. *, **, and *** indicate p < 0.05, p < 0.01, and p < 0.001 significance determined by one-way ANOVA, compared to vehicle treated ova s/c mice.